Tag : MS

Latest News

FDA Clears Ozanimod (Zeposia) for MS; COVID-19 Delays Launch

Newsemia
Ozanimod is the first oral, once-daily sphingosine-1-phosphate receptor modulator approved for adults with relapsing forms of multiple sclerosis. Source link...
Neurology

What Neurologists Can Expect From COVID-19

Newsemia
A discussion with Dr Kenneth Tyler on the most likely neurologic implications of the virus, and how the field can respond to the crisis. Medscape...
Neurology

For concussion, MS, other neurologic disorders, telemedicine may be as effective as office visit

Newsemia
An American Academy of Neurology (AAN) evidence review of all available studies on the use of telemedicine for several neurologic conditions indicate that a diagnosis from a neurologist by video for...
Neurology

'Intriguing Changes' in Gut Bacteria After MS Treatment

Newsemia
Significant changes in gut bacteria were observed in patients with multiple sclerosis within a month of treatment with ocrelizumab, a small, ongoing study reports. Medscape...
Neurology

Late 30s Could Be 'Critical Time' for Starting MS Therapy

Newsemia
A large study of patients with multiple sclerosis evaluated the interplay of age at disease onset and the timing of immunomodulatory therapy. Medscape Medical News...
Neurology

Unlocking the Mystery of Prodromal MS With a Key Biomarker

Newsemia
The promise of serum neurofilament light chain to diagnose multiple sclerosis continues to evolve, with new evidence supporting a role in identifying presymptomatic disease. Medscape...
Neurology

MESEMS: No Reduction in MS Lesions With Stem Cell Therapy

Newsemia
Although the primary outcome of a multinational phase 2 study was negative, researchers said promising secondary findings support the use of mesenchymal stem cells in...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy